Investigating the Therapeutic Potential of LSD1 Enzyme Activity-Specific Inhibition by TAK-418 for Social and Memory Deficits in Rodent Disease Models
Open Access
- 21 January 2022
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 13 (3) , 313-321
Abstract
Inhibition of lysine-specific demethylase 1 (LSD1) enzyme activity is a promising approach to treat diseases associated with epigenetic dysregulation, such as neurodevelopmental disorders. However, this concept has not been fully validated because genetic LSD1 deletion causes embryonic lethality and conventional LSD1 inhibitors cause thrombocytopenia via the dissociation of LSD1-cofactor complex. To characterize the therapeutic potential of LSD1 enzyme inhibition, we used TAK-418 and T-448, the LSD1 enzyme activity-specific inhibitors with minimal impact on the LSD1-cofactor complex. TAK-418 and T-448, by inhibiting brain LSD1 enzyme activity, consistently improved social deficits in animal models of neurodevelopmental disorders without causing thrombocytopenia. Moreover, TAK-418 improved memory deficits caused by aging or amyloid precursor protein overexpression. In contrast, TAK-418 did not improve memory deficits caused by miR-137 overexpression. Thus, miR-137 modulation may be involved in memory improvement by LSD1 inhibition. TAK-418 warrants further investigation as a novel therapeutic agent for diseases with epigenetic dysregulation.Keywords
Funding Information
- Takeda Pharmaceutical Company
This publication has 33 references indexed in Scilit:
- A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its InhibitorsMedicinal Research Reviews, 2015
- miR-137: A New Player in SchizophreniaInternational Journal of Molecular Sciences, 2014
- miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cellsNature Communications, 2011
- Molecular Mimicry and Ligand Recognition in Binding and Catalysis by the Histone Demethylase LSD1-CoREST ComplexStructure, 2011
- A Noncompetitive BACE1 Inhibitor TAK-070 Ameliorates Aβ Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2010
- Role of H3K4 Demethylases in Complex Neurodevelopmental DiseasesEpigenomics, 2010
- The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylationNature Genetics, 2008
- Epigenetic Regulation of Hematopoietic Differentiation by Gfi-1 and Gfi-1b Is Mediated by the Cofactors CoREST and LSD1Molecular Cell, 2007
- An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylationNature, 2005
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996